Abstract
In their recent perspective article [1], Bunnik et al. highlight the opportunities and challenges for clinicians as genomic testing becomes increasingly mainstreamed. Whole-exome and whole-genome sequencing is imminently becoming more available; genetic testing for germline variants are accessible for an increasing number of patients without required review in specialist genetic clinics. Genetic testing for germline mutations is offered in populations who are deemed to have a significant likelihood of a variant, e.g.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
